MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 239 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $238,099,000 | +32.4% | 4,536,941 | -16.1% | 0.02% | +23.1% |
| Q2 2020 | $179,866,000 | +50.5% | 5,406,248 | +23.0% | 0.01% | +30.0% |
| Q1 2020 | $119,515,000 | +58.3% | 4,393,952 | +14.8% | 0.01% | +100.0% |
| Q4 2019 | $75,518,000 | +62.7% | 3,827,583 | +6.9% | 0.01% | +66.7% |
| Q3 2019 | $46,403,000 | -0.5% | 3,580,501 | -4.4% | 0.00% | 0.0% |
| Q2 2019 | $46,625,000 | -14.2% | 3,744,948 | +0.1% | 0.00% | -25.0% |
| Q1 2019 | $54,338,000 | +31.9% | 3,739,677 | +0.2% | 0.00% | 0.0% |
| Q4 2018 | $41,190,000 | -48.9% | 3,730,943 | +21.8% | 0.00% | -33.3% |
| Q3 2018 | $80,538,000 | +14.5% | 3,062,179 | -11.0% | 0.01% | 0.0% |
| Q2 2018 | $70,325,000 | +9.4% | 3,438,794 | -2.9% | 0.01% | +20.0% |
| Q1 2018 | $64,280,000 | +39.7% | 3,541,646 | +7.3% | 0.01% | +25.0% |
| Q4 2017 | $46,024,000 | -15.0% | 3,299,241 | +12.8% | 0.00% | -20.0% |
| Q3 2017 | $54,117,000 | +20.7% | 2,925,418 | +10.3% | 0.01% | +25.0% |
| Q2 2017 | $44,842,000 | +36.8% | 2,653,427 | +8.1% | 0.00% | +33.3% |
| Q1 2017 | $32,776,000 | +16.0% | 2,455,449 | +30.8% | 0.00% | 0.0% |
| Q4 2016 | $28,266,000 | +37.6% | 1,877,945 | +6.9% | 0.00% | +50.0% |
| Q3 2016 | $20,539,000 | +18.2% | 1,756,847 | +9.2% | 0.00% | 0.0% |
| Q2 2016 | $17,370,000 | -9.2% | 1,608,412 | -22.4% | 0.00% | 0.0% |
| Q1 2016 | $19,137,000 | -34.6% | 2,071,668 | +5.0% | 0.00% | -33.3% |
| Q4 2015 | $29,272,000 | -25.9% | 1,972,525 | -18.1% | 0.00% | -40.0% |
| Q3 2015 | $39,511,000 | -22.5% | 2,407,665 | +7.8% | 0.01% | 0.0% |
| Q2 2015 | $50,954,000 | +40.4% | 2,233,832 | -6.4% | 0.01% | +25.0% |
| Q1 2015 | $36,284,000 | +41.8% | 2,387,265 | +12.3% | 0.00% | +33.3% |
| Q4 2014 | $25,596,000 | +5.6% | 2,126,335 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $24,244,000 | +2.8% | 2,137,877 | +9.5% | 0.00% | 0.0% |
| Q2 2014 | $23,589,000 | -1.1% | 1,952,696 | -4.7% | 0.00% | 0.0% |
| Q1 2014 | $23,860,000 | -45.6% | 2,048,020 | -30.7% | 0.00% | 0.0% |
| Q4 2013 | $43,828,000 | +51.5% | 2,953,292 | +46.9% | 0.00% | -25.0% |
| Q3 2013 | $28,921,000 | +41.6% | 2,009,944 | +48.2% | 0.00% | +33.3% |
| Q2 2013 | $20,429,000 | – | 1,356,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
| Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
| Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
| Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
| Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
| Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
| RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
| MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
| Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
| PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |